Cancer Prevention Pharmaceuticals

United States
Hope Valley, Rhode Island, United States, 85718

Company profile

Cancer Prevention Pharmaceuticals company profile

Cancer Prevention Pharmaceuticals, Inc. engages in the development and production of pharmaceutical agents to prevent cancers in people with elevated risk for these diseases in the United States. The company offers difluoro-methyl ornithine for clinical cancer prevention and treatment trials. It also develops diagnostic methods to identify individuals who are at high risk for specific cancers and medicine-related toxicities. In addition, the company develops cancer chemoprevention indications for common cancers along with prevention and therapeutic strategies in certain rare cancers. Cancer Prevention Pharmaceuticals, Inc. was incorporated in 2008 and is based in Tucson, Arizona.

Business identity

Contact email
[email protected]
Phone number
5203341491
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2008-01-01, Year

Headquarters

Postal code
85718
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
6
Total equity funding
$4.3M
Last funding
Debt Financing / $400,000 / 2021-01-29
Last equity funding
Series Unknown / $4.3M
Founders
2
Articles
11
Exited on
2022-02-22

Founders and investors

Founders

Eugene W. GernerFrank L. Meyskens